Academic Performance Programs: New Directions and (Dis)Connections in Academic Reform

The purpose of this paper is to provide a response to Harrison’s (2012) work. The author suggests that the one-size-fits all approach the National Collegiate Athletic Association (NCAA) has adopted when implementing academic reform measures ultimately hurts the athletes the reforms are intended to benefit

Higher Education Students’ Perceptions of Online Learning during the COVID-19 Pandemic

This article focuses on the impacts of online learning during the COVID-19 pandemic on students at the University of Hawai‘i at Hilo. Using survey data (n = 64) and semistructured interviews with currently enrolled students (n = 17), key impacts of online learning on the student body were analyzed. The respondents reported disengagement in lectures, negative impacts on their mental and physical health, negative thoughts about dropping out and transferring, apprehension about the quality of course content, and dissatisfaction with tuition. The paper utilizes qualitative data analysis to report the findings

Constructions of Generalized Sidon Sets

We give explicit constructions of sets S with the property that for each integer k, there are at most g solutions to k=s_1+s_2, s_i\in S; such sets are called Sidon sets if g=2 and generalized Sidon sets if g\ge 3. We extend to generalized Sidon sets the Sidon-set constructions of Singer, Bose, and Ruzsa. We also further optimize Koulantzakis' idea of interleaving several copies of a Sidon set, extending the improvements of Cilleruelo & Ruzsa & Trujillo, Jia, and Habsieger & Plagne. The resulting constructions yield the largest known generalized Sidon sets in virtually all cases.Comment: 15 pages, 1 figure (revision fixes typos, adds a few details, and adjusts notation

Long-Term Low-Level Arsenic Exposure Is Associated with Poorer Neuropsychological Functioning: A Project FRONTIER Study

Exposure to elements in groundwater (toxic or beneficial) is commonplace yet, outside of lead and mercury, little research has examined the impact of many commonly occurring environmental exposures on mental abilities during the aging process. Inorganic arsenic is a known neurotoxin that has both neurodevelopmental and neurocognitive consequences. The aim of this study was to examine the potential association between current and long-term arsenic exposure and detailed neuropsychological functioning in a sample of rural-dwelling adults and elders. Data were analyzed from 434 participants (133 men and 301 women) of Project FRONTIER, a community-based participatory research study of the epidemiology of health issues of rural-dwelling adults and elders. The results of the study showed that GIS-based groundwater arsenic exposure (current and long-term) was significantly related to poorer scores in language, visuospatial skills, and executive functioning. Additionally, long-term low-level exposure to arsenic was significantly correlated to poorer scores in global cognition, processing speed and immediate memory. The finding of a correlation between arsenic and the domains of executive functioning and memory is of critical importance as these are cognitive domains that reflect the earliest manifestations of Alzheimer’s disease. Additional work is warranted given the population health implications associated with long-term low-level arsenic exposure

Blacks in Massachusetts: Comparative Demographic, Social and Economic Experiences with Whites, Latinos, and Asians

This report describes the social and economic, and education status of Blacks in Massachusetts, within a comparative framework with Whites, Asians, and Latino/as. A range of population, household, and economic variables are highlighted under the following categories: Population Characteristics; Families and Households; Education and Schooling; Housing; Health Characteristics; Labor Force, Occupations and Employment; and Income and Poverty. The information presented in this report is based on data from the 2010 Decennial Census; the American Community Survey 2009 – 2013 5 Year Estimates; the American Community Survey 2009-2013 5-Year Estimates Public Use Microdata Sample (PUMS) as well as PUMS for the single year 2013; and the Current Population Survey’s Annual Social and Economic Supplement (2015), and other CPS reports

Validation of an Adapted Version of the Statistical Anxiety Scale in English and Its Relationship to Attitudes Toward Statistics

The aims of this study were to validate an instrument that measured statistics anxiety and to examine how attitudes toward statistics predict statistics anxiety using the Attitudes Toward Statistics (ATS) Scale for a sample of 323 undergraduate social science majors enrolled in colleges and universities in the United States. A confirmatory factor analysis suggested retaining a revised two-factor model of the Statistical Anxiety Scale (SAS) to measure statistics anxiety, namely, help and interpretation anxiety ([Formula: see text] = 49.37, df = 38.13, p = .105, comparative fit index [CFI] = .959, standardized root mean square residual [SRMR] = .035, root mean square error of approximation [RMSEA] = .076). An examination of discriminant validity of the scores of the SAS with scores of the ATS subscales revealed that statistics anxiety and attitudes toward statistics are distinct constructs. Structural equational modeling was used to determine whether attitude toward course and attitude toward field were predictors of examination anxiety and asking for help anxiety. Of the two factors of the ATS scale, attitudes toward field and attitudes toward course, the latter predicted examination anxiety better than the former did, although both were moderate predictors of examination anxiety. We recommend that statistics educators consider the role of statistics anxiety as well as attitudes toward statistics and the field when designing their pedagogical approach.</jats:p

A precision medicine initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling

After intense scientific exploration and more than a decade of failed trials, Alzheimer’s disease (AD) remains a fatal global epidemic. A traditional research and drug development paradigm continues to target heterogeneous late-stage clinically phenotyped patients with single 'magic bullet' drugs. Here, we propose that it is time for a paradigm shift towards the implementation of precision medicine (PM) for enhanced risk screening, detection, treatment, and prevention of AD. The overarching structure of how PM for AD can be achieved will be provided through the convergence of breakthrough technological advances, including big data science, systems biology, genomic sequencing, blood-based biomarkers, integrated disease modeling and P4 medicine. It is hypothesized that deconstructing AD into multiple genetic and biological subsets existing within this heterogeneous target population will provide an effective PM strategy for treating individual patients with the specific agent(s) that are likely to work best based on the specific individual biological make-up. The Alzheimer’s Precision Medicine Initiative (APMI) is an international collaboration of leading interdisciplinary clinicians and scientists devoted towards the implementation of PM in Neurology, Psychiatry and Neuroscience. It is hypothesized that successful realization of PM in AD and other neurodegenerative diseases will result in breakthrough therapies, such as in oncology, with optimized safety profiles, better responder rates and treatment responses, particularly through biomarker-guided early preclinical disease-stage clinical trials

Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin

Nephrotoxicity is a dose limiting side effect associated with the use of cisplatin in the treatment of solid tumors. The degree of nephrotoxicity is dictated by the selective accumulation of cisplatin in renal tubule cells due to: (1) uptake by organic cation transporter 2 (OCT2) and copper transporter 1 (CTR1); (2) metabolism by glutathione S-transferases (GSTs) and γ-glutamyltransferase 1 (GGT1); and (3) efflux by multidrug resistance-associated protein 2 (MRP2) and multidrug and toxin extrusion protein 1 (MATE1). The purpose of this study was to determine the significance of single nucleotide polymorphisms that regulate the expression and function of transporters and metabolism genes implicated in development of acute kidney injury (AKI) in cisplatin treated patients. Changes in the kidney function were assessed using novel urinary protein biomarkers and traditional markers. Genotyping was conducted by the QuantStudio 12K Flex Real-Time PCR System using a custom open array chip with metabolism, transport, and transcription factor polymorphisms of interest to cisplatin disposition and toxicity. Traditional and novel biomarker assays for kidney toxicity were assessed for differences according to genotype by ANOVA. Allele and genotype frequencies were determined based on Caucasian population frequencies. The polymorphisms rs596881 (SLC22A2/OCT2), and rs12686377 and rs7851395 (SLC31A1/CTR1) were associated with renoprotection and maintenance of estimated glomerular filtration rate (eGFR). Polymorphisms in SLC22A2/OCT2, SLC31A1/CTRI, SLC47A1/MATE1, ABCC2/MRP2, and GSTP1 were significantly associated with increases in the urinary excretion of novel AKI biomarkers: KIM-1, TFF3, MCP1, NGAL, clusterin, cystatin C, and calbindin. Knowledge concerning which genotypes in drug transporters are associated with cisplatin-induced nephrotoxicity may help to identify at-risk patients and initiate strategies, such as using lower or fractionated cisplatin doses or avoiding cisplatin altogether, in order to prevent AKI

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

Alzheimer’s Disease (AD) is the most common form of dementia, characterised by extracellular amyloid deposition as plaques and intracellular neurofibrillary tangles of tau protein. As no current clinical test can diagnose individuals at risk of developing AD, the aim of this project is to evaluate a blood-based biomarker panel to identify individuals who carry this risk. We analysed the levels of 22 biomarkers in clinically classified healthy controls (HC), mild cognitive impairment (MCI) and Alzheimer’s participants from the well characterised Australian Imaging, Biomarker and Lifestyle (AIBL) study of aging. High levels of IL-10 and IL-12/23p40 were significantly associated with amyloid deposition in HC, suggesting that these two biomarkers might be used to detect at risk individuals. Additionally, other biomarkers (Eotaxin-3, Leptin, PYY) exhibited altered levels in AD participants possessing the APOE ε4 allele. This suggests that the physiology of some potential biomarkers may be altered in AD due to the APOE ε4 allele, a major risk factor for AD. Taken together, these data highlight several potential biomarkers that can be used in a blood-based panel to allow earlier identification of individuals at risk of developing AD and/or early stage AD for which current therapies may be more beneficial